Park and group reported PEGylated hyaluronic acid (HA)-coated exosomes to target the CD44-overexpressing cells actively and verified the targetability using the RA and PC3 tumor-bearing mouse models, representative models of CD44-overexpression [121]. Here, CD44 is linked to neoplasm.